Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,303.10 +8.60 0.06%
S&P 500 1,649.60 -0.91 -0.06%
Nasdaq 3,459.14 -0.27 -0.01%
Ticker Volume Price Price Delta
STOXX 50 2,764.29 -12.49 -0.45%
FTSE 100 6,654.34 -42.45 -0.63%
DAX 8,305.32 -46.66 -0.56%
Ticker Volume Price Price Delta
Nikkei 14,612.50 +128.47 0.89%
Hang Seng 22,618.70 -51.01 -0.23%
S&P/ASX 200 4,983.50 -78.95 -1.56%
  • Fund Type: Open-End Fund
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: Global

Aberdeen Swiss Funds Global Pharma Equity Fund

+ Add to Watchlist

SVBPHNI:SW

1,391.31 USD 12.55 0.89%

As of 00:59:30 ET on 05/23/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for Aberdeen Swiss Funds Global Pharma Equity Fund (SVBPHNI)

Year To Date: +17.58% 3-Month: +9.82% 3-Year: +17.70% 52-Week Range: 1,022.76 - 1,406.80
1-Month: +1.87% 1-Year: +34.63% 5-Year: +7.64% Beta vs NDWUHC: 0.95

Mutual Fund Chart for SVBPHNI

No chart data available.
  • SVBPHNI:SW 1,391.31
  • 1M
  • 1Y
Interactive SVBPHNI Chart

Previous Close

Fund Profile & Information for SVBPHNI

Aberdeen Swiss Equity Fund Global Pharma is an open-end fund incorporated in Switzerland. The Fund invests worldwide in companies that are active in the pharmaceuticals, biotechnology and medical technology sectors. The Fund focuses on the United States and offers investors a transparent way to invest in the complex pharmaceuticals and biotechnology sectors.

Inception Date: 09-30-1959 Telephone: 41-44-335-11-11 Tel
Managers: -
Web Site: www.credit-suisse.com

Fundamentals for SVBPHNI

NAV (on 2013-05-23) 1,391.31
Assets (M) (on 2013-05-23) 163.93
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for SVBPHNI

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2012-11-20) 8.40
Dividend Yield (ttm) 0.60

Fees & Expenses for SVBPHNI

Front Load -
Back Load -
Current Mgmt Fee 1.60
Redemption Fee -
12b1 Fee -
Expense Ratio 1.66

Top Fund Holdings for SVBPHNI

Filing Date: 03/27/2013
Name Position Value % of Total
Novartis AG 193,600 13,624,794 8.542%
Roche Holding AG 57,800 13,306,518 8.343%
Johnson & Johnson 154,300 12,539,961 7.862%
CVS Caremark Corp 215,000 11,822,850 7.413%
Novo Nordisk A/S 63,400 10,274,208 6.442%
Baxter International Inc 138,600 9,962,568 6.246%
Astellas Pharma Inc 176,400 9,495,714 5.954%
L'Oreal SA 51,400 7,925,991 4.969%
Waters Corp 77,800 7,247,848 4.544%
Quest Diagnostics Inc 125,800 7,095,120 4.448%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil